Damien JOLLY
Reims, France
NCT Number: NCT03623204
Obesity, defined as a Body Mass Index greater than or equal to 30 kg/m2, represents a significant public health issue. Dyspnea is a very common and crippling symptom in obesity. About 80% of people with obesity experience dyspnea in daily living. Bariatric surgery has been demonstrated to be an excellent treatment for obesity by inducing significant weight loss. Nevertheless, changes in dyspnea in daily living after bariatric surgery and the links between variations in dyspnea and lung function tests after bariatric surgery have not been previously investigated.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Reims, France
The objective of this study was to determine if bariatric surgery is associated with an improvement of dyspnea in daily living according to the mMRC scale in patients with obesity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Month 6
Dyspnea in daily living evaluated using the mMRC scale
Time frame: Month 12
Dyspnea in daily living evaluated using the mMRC scale
CHU de Reims
Other
Acronym: OBES-DYSP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06474858
Body Weight, COPD
Arnhem, Netherlands
View Trial DetailsNCT03621098
Behavior, Body Weight
Winston-Salem, North Carolina, United States
View Trial DetailsNCT02832609
Body Weight, Dyspnea
Lyon, France
View Trial DetailsNCT03035149
Body Weight, Dyspnea
Ottawa, Ontario, Canada
View Trial Details